Symatese is a science-based company focused on tissue regeneration, reconstruction and medical delivery systems. Drawing on more than 25 years of experience serving physicians and patients, it develops and produces technological solutions for therapeutic, cosmetic and aesthetic applications. Its work spans more than 15 medical specialties, including wound healing, dermatology, orthopaedics, ophthalmic surgery and plastic and reconstructive surgery.

The company’s expertise combines collagen, hyaluronic acid, silicones and thermoplastics. Its collagen technologies support applications such as dermal regeneration, surgical hemostasis, cardiovascular surgery and bone reconstruction. Symatese also develops cross-linked hyaluronic acid products for facial rejuvenation and therapeutic uses, including joint and dry-eye treatments. Its silicone capabilities include breast implants, while thermoplastic processing enables the production of medical-device components and delivery systems.

Symatese’s portfolio includes solutions for dermal reconstruction, aesthetic medicine, breast and body implants, and customized implants, as well as syringes, injectors and other administration systems. The company also works in tissue regeneration for cosmetics and has a partnership with L’Oréal in this field.